pixelized colorful circle

Your AI Antibody Design Partner

Accelerate antibody development through AI-powered innovations in molecule design and optimization, creating tomorrow’s therapies today.

Animated 3D ribbon structure of an antibody domain

WHO IT’S FOR

One design partner across discovery, deals, and diligence

R&D leads

Move from target to developable leads faster. Generate and rank candidates in silico, then send only the strongest designs to the lab.

BD teams

Bring differentiated antibody programs to partnering conversations, backed by computational evidence on binding and developability.

pixelized colorful circle

ANTIBODY DESIGN & SCREENING

Engineer precise antibodies

AI-driven design, screening, and optimization across every stage of antibody engineering, so only the strongest candidates reach the lab.

Input types

IgG

ScFv

VHH

Bispecifics

01

Affinity maturation

02

Developability optimization

03

Expression optimization

04

Humanization

05

Cross-reactivity and specificity

06

pH dependent binding

07

IP generation

08

IP fortification

01

Affinity maturation

Speed up antibody engineering with AI-guided design and ranking, cutting slow, iterative lab cycles.

02

Developability optimization

Identify the candidates most likely to succeed early, and skip costly trial-and-error.

03

Expression optimization

Design sequences that express at high titers, removing liabilities early to boost yield.

04

Humanization

Lower immunogenicity risk while preserving the affinity and function of the parental molecule.

05

Cross-reactivity and specificity

Tune binding across species for preclinical models, or minimize off-target binding.

06

pH dependent binding

Bind tightly at physiological pH and release in endosomes for longer half-life.

07

IP generation

Generate novel, diverse sequences beyond known space with a clear path to patent claims.

08

IP fortification

Explore functional variants around your leads to broaden claims and block design-arounds.

HOW IT WORKS

From target to pre‑clinical ready

Iterate and refine

6 weeks

48

48

Candidates chosen for screening per round

Candidates chosen for screening per round

Sequence

Target Product Profile

Generate Candidates

Wet-lab Testing

Achieved Target Product Profile

pixelized colorful circle

See Converge in action

See Converge in action

See Converge in action